[Prostate cancer 2010. Therapeutic innovations]

Cancer Radiother. 2011 Mar;15(2 Suppl):7-11. doi: 10.1016/S1278-3218(11)70002-6.
[Article in French]

Abstract

During the annual congress of the SFRO, a symposium, on "Therapeutic innovations", described some of the burning questions in the treatment of prostate cancer. What is the best technique to perform radiation dose escalation, brachytherapy or Intensity modulated radiotherapy? Rational has been highlighted for both techniques, but without a prospective comparative trial, no definitive answer could be given today. The role of neo-adjuvant hormonal treatment, before surgery or radiotherapy is still discussed, particularly in the area of LH-RH antagonists which have a rapid and profound anti-hormonal effect. At least, the salvage treatment for biochemical relapse after external beam irradiation has been discussed: surgery, cryotherapy, and High-Intensity focalised ultrasons and the timing of hormonal treatment.

Publication types

  • English Abstract

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Congresses as Topic
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors
  • Humans
  • Male
  • Neoadjuvant Therapy
  • Neoplasm Recurrence, Local / therapy
  • Prostatectomy
  • Prostatic Neoplasms / therapy*
  • Radiotherapy Dosage
  • Radiotherapy, Conformal
  • Radiotherapy, Intensity-Modulated
  • Societies, Medical

Substances

  • Antineoplastic Agents, Hormonal
  • Gonadotropin-Releasing Hormone